Novanta, a US company, is facing trade tensions and uncertainty regarding customer orders from China.
2 reports, 1 independent
Updated Aug 13
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novanta, a US company, is facing trade tensions and uncertainty regarding customer orders from China.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- U.S.–China trade tensions are impacting China sales for Thermo Fisher Scientific Inc.Sub-event
Novanta faces trade tensions and customer order uncertainty due to issues with China.1 source
Novanta is seeing product growth but is also facing trade disruptions and sluggish end-market dynamics.1 source
Keep exploring
The entities involved
-
Novanta (United States)
organization
Nothing else this week.
-
China
cultural region, ancient civilization, and nation in East Asia; mostly refers to the People's Republic of China in political situation and rarely refers to the Republic of China
Coverage
Newest first; wire copies grouped- StockStoryNOVT Q2 Deep Dive: Medical Device Growth Offset by Guidance Caution and Trade Uncertainty Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations
- StockStory5 Insightful Analyst Questions From Novanta’s Q2 Earnings Call Novanta’s second quarter was marked by strong execution in its core medical and automation markets, but the market responded negatively